ANR ASX News

14 January 2025

New!
Quarterly Activities/Appendix 4C Cash Flow Report

Anatara Lifesciences pauses recruitment for GaRP-IBS trial, with results expected in Q1 2025.

Anatara Lifesciences GaRP-IBS Trial Clinical Trials Digestive Health Market Stock Market News

Posted on: 14/01/2025

Read More

12 December 2024

GaRP-IBS Clinical Trial Update

Anatara Lifesciences pauses GaRP-IBS trial recruitment after exceeding enrollment targets.

Anatara Lifesciences Clinical Trials GaRP-IBS Stock Market News Biotechnology

Posted on: 12/12/2024

Read More

3 December 2024

GaRP-IBS Clinical Trial Update

Anatara Lifesciences nears recruitment goal for GaRP-IBS trial's Stage 2.

Anatara Lifesciences GaRP-IBS Trial Clinical Trials Biotechnology Gastrointestinal Health

Posted on: 03/12/2024

Read More

26 November 2024

Share Purchase Plan Offer Booklet

Anatara Lifesciences offers a Share Purchase Plan to raise $0.5 million.

Anatara Lifesciences Share Purchase Plan Equity Raising Biotechnology Clinical Studies

Posted on: 26/11/2024

Read More

14 November 2024

Successful Placement of $660k and Share Purchase Plan

Anatara Lifesciences raises $1.16 million for IBS and anti-obesity projects.

Anatara Lifesciences IBS Treatment Stock Market News Biotechnology Clinical Trials

Posted on: 14/11/2024

Read More

12 November 2024

Trading Halt

Anatara Lifesciences halts trading pending a capital raising announcement.

Anatara Lifesciences Capital Raising Trading Halt Stock Market News

Posted on: 12/11/2024

Read More
Pause in Trading

Anatara Lifesciences pauses trading pending further announcement.

Anatara Lifesciences Trading Halt Stock Market News Biotechnology

Posted on: 12/11/2024

Read More

31 October 2024

Appendix 4C & Q1 FY25 Activities Report

Anatara Lifesciences progresses GaRP-IBS trial and secures European patent.

Anatara Lifesciences GaRP-IBS Trial European Patent Stock Market News Biotechnology

Posted on: 31/10/2024

Read More